Skip to main content

Animations

MJFF Publications

5721 - 5730 of 8823 Results
Title
Year
  • Year
  • 2016
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2021
  • Summary Details
    OPEN
    Title: Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/ana.24781
    Citation Count: 273
  • Summary Details
    OPEN
    Title: A Markov random field model-based approach for differentially expressed gene detection from single-cell RNA-seq data
    Journal Name: Briefings in Bioinformatics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/bib/bbac166
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000200745
    Citation Count: 67
  • Summary Details
    OPEN
    Title: Genetics of validated Parkinson’s disease subtypes in the Oxford Discovery and Tracking Parkinson’s cohorts
    Journal Name: Journal of Neurology, Neurosurgery & Psychiatry
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1136/jnnp-2021-327376
    Citation Count: 11
  • Summary Details
    OPEN
    Title: GBA and APOE Impact Cognitive Decline in Parkinson's Disease: A 10‐Year Population‐Based Study
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28932
    Citation Count: 113
  • Summary Details
    OPEN
    Title: Structure of the second phosphoubiquitin–binding site in parkin
    Journal Name: Journal of Biological Chemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.jbc.2022.102114
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Multiple N-of-1 trials to investigate hypoxia therapy in Parkinson’s disease: study rationale and protocol
    Journal Name: BMC Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12883-022-02770-7
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Astrocytic α2-Na + /K + ATPase inhibition suppresses astrocyte reactivity and reduces neurodegeneration in a tauopathy mouse model
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.abm4107
    Citation Count: 71
  • Summary Details
    OPEN
    Title: Distinct profiles of LRRK2 activation and Rab GTPase phosphorylation in clinical samples from different PD cohorts
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00336-5
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Proposed research criteria for prodromal behavioural variant frontotemporal dementia
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awab365
    Citation Count: 95
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.